A syngeneic orthotopic murine model of pancreatic adenocarcinoma in the C57/BL6 mouse using the panc02 and 6606PDA cell lines

European Surgical Research

Volumn 47, Issue 2, 2011, Pages 98-107

  Partecke, L I ^a   Sendler, M ^a   Kaeding, A ^a   Weiss, F U ^a   Mayerle, J ^a   Dummer, A ^a   Nguyen, T D ^a   Albers, N ^a   Speerforck, S ^a   Lerch, M M ^a   Heidecke, C D ^a   Von Bernstorff, W ^a   Stier, A ^b  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b HELIOS KLINIKUM ERFURT   (Germany)

Author keywords

6606PDA; Immunocompetent mice; Mouse cell lines; MRI; Orthotopic murine model; Panc02; Pancreatic cancer

Indexed keywords

MATRIGEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; HISTOLOGY; HUMAN; IMMUNOCOMPETENCE; IN VITRO STUDY; MALE; MONITORING; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PERITONEUM TUMOR; PRIORITY JOURNAL; SARCOMA; TUMOR GROWTH;

ANIMALS; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN; DRUG COMBINATIONS; HUMANS; LAMININ; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PANCREATIC NEOPLASMS; PROTEOGLYCANS; TIME FACTORS; TRANSPLANTATION, ISOGENEIC;

EID: 79959681935     PISSN: 0014312X     EISSN: 14219921     Source Type: Journal    
DOI: 10.1159/000329413     Document Type: Article

References (33)

1. Greenlee RT, Murray T, Bolden S, Wingo PA: Cancer statistics, 2000. CA Cancer J Clin 2000; 50: 7-33. (Pubitemid 30072093)
2. Kern S, Hruban R, Hollingsworth MA, Brand R, Adrian TE, Jaffee E, Tempero MA: A white paper: The product of a pancreas cancer think tank. Cancer Res 2001; 61: 4923-4932. (Pubitemid 32694386)
3. Robert-Koch-Institut: Krebs in Deutschland: Bauchspeicheldrüse. Berlin, Robert-Koch-Institut, 2009.
4. Li D, Xie K, Wolff R, Abbruzzese JL: Pancreatic cancer. Lancet 2004; 363: 1049-1057. (Pubitemid 38410779)
5. Braakman E, Goedegebuure PS, Vreugdenhil RJ, Segal DM, Shaw S, Bolhuis RL: ICAMmelanoma cells are relatively resistant to CD3-mediated T-cell lysis. Int J Cancer 1990; 46: 475-480. (Pubitemid 20291106)
6. Chan AK, Goedegebuure PS, von Bernstorff W, Carritte AL, Chung M, Stewart RA, Montgomery L, Spanjaard RA, McKenzie AB, Eberlein TJ: B7.1 costimulation increases T-cell proliferation and cytotoxicity via selective expansion of specific variable alpha and beta genes of the T-cell receptor. Surgery 2000; 127: 342-350. (Pubitemid 30140634)
7. Chen L, Ashe S, Brady WA, Hellstrom I, Hellstrom KE, Ledbetter JA, McGowan P, Linsley PS: Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 1992; 71: 1093-1102. (Pubitemid 23016545)
8. Bernstorff WV, Glickman JN, Odze RD, Farraye FA, Joo HG, Goedegebuure PS, Eberlein TJ: Fas (CD95/APO-1) and Fas ligand expression in normal pancreas and pancreatic tumors. Implications for immune privilege and immune escape. Cancer 2002; 94: 2552-2560. (Pubitemid 34478067)
9. von Bernstorff W, Spanjaard RA, Chan AK, Lockhart DC, Sadanaga N, Wood I, Peiper M, Goedegebuure PS, Eberlein TJ: Pancreatic cancer cells can evade immune surveillance via nonfunctional Fas (APO-1/CD95) receptors and aberrant expression of functional Fas ligand. Surgery 1999; 125: 73-84. (Pubitemid 29063174)
10. Voss M, Wolff B, Savitskaia N, Ungefroren H, Deppert W, Schmiegel W, Kalthoff H, Naumann M: TGFα -induced growth inhibition involves cell cycle inhibitor p21 and pRb independent from p15 expression. Int J Oncol 1999; 14: 93-101.
11. Holland G, Zlotnik A: Interleukin-10 and cancer. Cancer Invest 1993; 11: 751-758. (Pubitemid 23361111)
12. Chan AK, Lockhart DC, von Bernstorff W, Spanjaard RA, Joo HG, Eberlein TJ, Goedegebuure PS: Soluble MUC1 secreted by human epithelial cancer cells mediates immune suppression by blocking T-cell activation. Int J Cancer 1999; 82: 721-726. (Pubitemid 29356972)
13. von Bernstorff W, Voss M, Freichel S, Schmid A, Vogel I, Johnk C, Henne-Bruns D, Kremer B, Kalthoff H: Systemic and local immunosuppression in pancreatic cancer patients. Clin Cancer Res 2001; 7: 925s-932s. (Pubitemid 33600947)
14. Dunschede F, Will L, von Langsdorf C, Mohler M, Galle PR, Otto G, Vahl CF, Junginger T: Treatment of metachronous and simultaneous liver metastases of pancreatic cancer. Eur Surg Res 2010; 44: 209-213.
15. Corbett TH, Roberts BJ, Leopold WR, Peckham JC, Wilkoff LJ, Griswold DP Jr, Schabel FM Jr: Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice. Cancer Res 1984; 44: 717-726. (Pubitemid 14184610)
16. Liang CC, Park AY, Guan JL: In vitro scratch assay: A convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2007; 2: 329-333. (Pubitemid 47040047)
17. Schmidt M, Deschner EE, Thaler HT, Clements L, Good RA: Gastrointestinal cancer studies in the human to nude mouse heterotransplant system. Gastroenterology 1977; 72: 829-837. (Pubitemid 8093889)
18. Peiper M, Nagoshi M, Patel D, Fletcher JA, Goegebuure PS, Eberlein TJ: Human pancreatic cancer cells (MPanc-96) recognized by autologous tumor-infiltrating lymphocytes after in vitro as well as in vivo tumor expansion. Int J Cancer 1997; 71: 993-999. (Pubitemid 27252882)
19. von Bernstorff W, Peiper M, Goedegebuure PS, Eberlein TJ: Etablierung einer neuen humanen Pankreaskarzinomzelllinie als in vitro und in vivo Modell für die adaptive Immuntherapie und zur Identifizierung tumorspezifischer Antigene beim Pan kre askarzinom. Langenbecks Arch Chir 1997; (suppl I):47-50.
20. Tan MH, Nowak NJ, Loor R, Ochi H, Sandberg AA, Lopez C, Pickren JW, Berjian R, Douglass HO Jr, Chu TM: Characterization of a new primary human pancreatic tumor line. Cancer Invest 1986; 4: 15-23. (Pubitemid 16103427)
21. Fidler IJ: Modulation of the organ microenvironment for treatment of cancer metastasis. J Natl Cancer Inst 1995; 87: 1588-1592.
22. Thalheimer A, Otto C, Bueter M, Illert B, Gattenlohner S, Gasser M, Fein M, Germer CT, Waaga-Gasser AM: Tumor cell dissemination in a human colon cancer animal model: Orthotopic implantation or intraportal injection? Eur Surg Res 2009; 42: 195-200.
23. Bibby MC: Orthotopic models of cancer for preclinical drug evaluation: Advantages and disadvantages. Eur J Cancer 2004; 40: 852-857. (Pubitemid 38519764)
24. Talmadge JE, Singh RK, Fidler IJ, Raz A: Murine models to evaluate novel and conventional therapeutic strategies for cancer. Am J Pathol 2007; 170: 793-804. (Pubitemid 47339349)
25. Deng M, Huang H, Dirsch O, Dahmen U: Effect and risk of AEE788, a dual tyrosine kinase inhibitor, on regeneration in a rat liver resection model. Eur Surg Res 2010; 44: 82-95.
26. Hribaschek A, Meyer F, Ridwelski K, Kuester D, Lippert H: Oxaliplatin for chemotherapeutic treatment and prevention of experimental peritoneal carcinomatosis in rats comparing the intraperitoneal and intravenous application mode. Eur Surg Res 2010; 44: 74-81.
27. Tuveson DA, Zhu L, Gopinathan A, Willis NA, Kachatrian L, Grochow R, Pin CL, Mitin NY, Taparowsky EJ, Gimotty PA, Hruban RH, Jacks T, Konieczny SF: Mist1-KrasG12D knock-in mice develop mixed differentiation metastatic exocrine pancreatic carcinoma and hepatocellular carcinoma. Cancer Res 2006; 66: 242-247. (Pubitemid 43166030)
28. Ishizu K, Sunose N, Yamazaki K, Tsuruo T, Sadahiro S, Makuuchi H, Yamori T: Development and characterization of a model of liver metastasis using human colon cancer HCT-116 cells. Biol Pharm Bull 2007; 30: 1779-1783. (Pubitemid 47403265)
29. Singh B, Cook KR, Martin C, Huang EH, Mosalpuria K, Krishnamurthy S, Cristofanilli M, Lucci A: Evaluation of a CXCR4 antagonist in a xenograft mouse model of inflammatory breast cancer. Clin Exp Metastasis 2010; 27: 233-240.
30. Koo V, Hamilton PW, Williamson K: Noninvasive in vivo imaging in small animal research. Cell Oncol 2006; 28: 127-139. (Pubitemid 44427396)
31. Schmidt GP, Wintersperger B, Graser A, Baur-Melnyk A, Reiser MF, Schoenberg SO: High-resolution whole-body magnetic resonance imaging applications at 1.5 and 3 tesla: A comparative study. Invest Radiol 2007; 42: 449-459. (Pubitemid 46788746)
32. Ranefall P, Bidar AW, Hockings PD: Automatic segmentation of intra-abdominal and subcutaneous adipose tissue in 3D whole mouse MRI. J Magn Reson Imaging 2009; 30: 554-560.
33. Wang H, Van de Putte M, Chen F, De Keyzer F, Jin L, Yu J, Marchal G, de Witte P, Ni Y: Murine liver implantation of radiation-induced fibrosarcoma: Characterization with MR imaging, microangiography and histopathology. Eur Radiol 2008; 18: 1422-1430.